| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/03/2001 | EP0828759B1 Process of high purity albumin production |
| 01/03/2001 | EP0785773B1 Ether lipid liposomes and their therapeutic use |
| 01/03/2001 | EP0722312B1 Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it |
| 01/03/2001 | EP0711546B1 Ophthalmic solution based on diclofenac and tobramycine and its applications |
| 01/03/2001 | EP0702568B1 An emollient composition |
| 01/03/2001 | EP0662822B1 Two-phase matrix for sustained release drug delivery device |
| 01/03/2001 | CN1278853A Gel-form pressure-sensitive adhesive, and adhesive material and adhesive medicinal preparation both containing the same |
| 01/03/2001 | CN1278738A Release-sustaining agent for drugs and sustained-release pharmaceutical composition containing same |
| 01/03/2001 | CN1278737A Method for decreasing self-association of polypeptides |
| 01/03/2001 | CN1278736A Hmanized antibodies to human gp39, compositions containing and therapeutic use thereof |
| 01/03/2001 | CN1278735A Vaginal suppository vaccine for urogenital infections |
| 01/03/2001 | CN1278733A Viscous compositions containing carbon dioxide |
| 01/03/2001 | CN1278730A Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters |
| 01/03/2001 | CN1278723A Percutaneously absorbable preparation |
| 01/03/2001 | CN1278440A Changshouguo fruit capsule and its preparation |
| 01/03/2001 | CN1278439A Chinese medicine bolus for treating tumor and its compounding process |
| 01/03/2001 | CN1278429A Controlled-releasing vaginal tinidazole collyrium and its preparation |
| 01/03/2001 | CN1060178C Derivatives of structurally modified vip and pharmacetical compositions containing them for treating servual impotense of male |
| 01/03/2001 | CN1060164C SIN-IA cyclodextriun inclusion complexes |
| 01/03/2001 | CN1060126C Bag for medicine or food |
| 01/03/2001 | CN1060088C Plaster for treating bone, joint, nerve and musde diseases and preparation method thereof |
| 01/03/2001 | CN1060087C Traditional Chinese medicine extract tablet and preparation method therefor |
| 01/03/2001 | CN1060081C Pure Chinese medicinal srup preparation and its production tech. |
| 01/03/2001 | CN1060073C Externally used medicine bag for curing chroic pelvic infection, endometriosis, chronic cervicitis and menalgia and its making process |
| 01/03/2001 | CN1060070C External application medicinal bag for curing acute and chronic cholecystitis and its producing method |
| 01/03/2001 | CN1060068C Ointment of drawing ot pus for curing bone inflammation and preparation technology thereof |
| 01/03/2001 | CN1060064C Non-toxic sedative anticancer Chinese medicine capsule |
| 01/03/2001 | CN1060056C Adhesive plaster for curing osteomyelitis |
| 01/03/2001 | CN1060054C 'Funaowan'-medicinal pill for recovering brains and production technology thereof |
| 01/03/2001 | CN1060051C Anti-cancer compn. and prepn. thereof |
| 01/03/2001 | CN1060046C Nutritive health products of wood frog oil |
| 01/03/2001 | CN1060043C Animal medicinal composition |
| 01/03/2001 | CN1060042C Stabilized prostaglandin E1 |
| 01/03/2001 | CN1060041C Aqueous composition |
| 01/03/2001 | CN1060038C Elemene emulsion injection and its preparing process |
| 01/03/2001 | CN1060037C Effervescent granulated material and method for its preparation |
| 01/02/2001 | US6169130 Method for improving the dispersion of redispersible polymer powders |
| 01/02/2001 | US6169118 Two flavoring oils and lauryl alcohol for use in an orally administered formulation |
| 01/02/2001 | US6169117 Increasing the oxygen concentration of the blood while avoiding the formation of bubbles which tend to occlude capillaries |
| 01/02/2001 | US6169114 Endermic liniment containing a thiol compound and zinc oxide |
| 01/02/2001 | US6169100 Pharmaceutical composition |
| 01/02/2001 | US6169099 Pharmaceutical composition |
| 01/02/2001 | US6169084 2-methyl-thieno-benzodiazepine formulation |
| 01/02/2001 | US6169083 Administering an l-carnosine zinc salt or l-carnosine-zinc complex; treating the side effect of cancer chemotherapy or radiotherapy |
| 01/02/2001 | US6169069 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating the eyes or eyelids |
| 01/02/2001 | US6169068 Treating lung disease or disorder by inhalating a protein |
| 01/02/2001 | US6168806 Orally administrable nifedipine pellet and process for the preparation thereof |
| 01/02/2001 | US6168805 Aqueous process for manufacturing paroxetine solid dispersions |
| 01/02/2001 | US6168804 Slow release antigen delivery systems; oligopeptide; monophosphoryl lipid a |
| 01/02/2001 | US6168801 Controlled release drug delivery |
| 01/02/2001 | US6168799 β-D-glucan topical composition |
| 01/02/2001 | US6168587 Needleless syringe using supersonic gas flow for particle delivery |
| 01/02/2001 | US6167887 Selected C-10 perfluorinated hydrocarbons for liquid ventilation and artificial blood |
| 01/02/2001 | US6167880 Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume |
| 01/02/2001 | CA2194221C Cationic amphiphiles |
| 01/02/2001 | CA2075060C Novel vehicle gases and their use in medical preparations |
| 01/02/2001 | CA2071837C Vitamin-mineral treatment methods and compositions |
| 01/02/2001 | CA2027596C Compositions containing hyaluronic acid complexes with zinc or cobalt |
| 01/02/2001 | CA2019218C Magnetic protein conjugates, a process for the preparation thereof and the use thereof |
| 01/01/2001 | WO2001003645A2 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 12/30/2000 | CA2313011A1 Encapsulation of active ingredients |
| 12/28/2000 | WO2000079010A1 Compositions and methods for preventing transepithelial transmission of hiv |
| 12/28/2000 | WO2000078941A2 Methods and products for manipulating uncoupling protein expression |
| 12/28/2000 | WO2000078937A1 Methods for ameliorating icthyosiform skin diseases |
| 12/28/2000 | WO2000078924A1 Method for the preservation of biologically-active material |
| 12/28/2000 | WO2000078846A1 Degradable cross-linking agents and cross-linked network polymers formed therewith |
| 12/28/2000 | WO2000078805A1 Peptide having preptin functionality |
| 12/28/2000 | WO2000078792A1 Method for purification of proteins |
| 12/28/2000 | WO2000078777A1 Propargyl phenyl ether a2a receptor agonists |
| 12/28/2000 | WO2000078772A2 Antibiotic agents |
| 12/28/2000 | WO2000078697A2 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof |
| 12/28/2000 | WO2000078358A2 Hyaluronic acid microspheres for sustained gene transfer |
| 12/28/2000 | WO2000078357A2 Hyaluronic acid film and matrix for sustained gene transfer |
| 12/28/2000 | WO2000078356A1 Injectable hyaluronate-sulfated polysaccharide conjugates |
| 12/28/2000 | WO2000078354A1 Topical composition comprising acetyl salicylic acid |
| 12/28/2000 | WO2000078353A2 Aqueous immunologic adjuvant compositions of monophosphoryl lipid a |
| 12/28/2000 | WO2000078340A1 Sustained release preparations of physiologically active peptides |
| 12/28/2000 | WO2000078335A1 COMPOSITIONS FOR CONTROLLED RELEASE OF THE HORMONE GnRH AND ITS ANALOGS |
| 12/28/2000 | WO2000078332A2 Fish serine proteinases and their pharmaceutical and cosmetic use |
| 12/28/2000 | WO2000078323A1 A use of icariin in preparing the medicine for preventing and treating sexual disorder and vasoconstrictive diseases |
| 12/28/2000 | WO2000078322A2 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 12/28/2000 | WO2000078318A1 Medicinal composition for oral administration |
| 12/28/2000 | WO2000078307A1 Orally administrable pharmaceutical preparation having therapeutic effect on gastrointestinal disorders comprising coated ranitidine, bismuth subcitrate and sucralfate |
| 12/28/2000 | WO2000078302A1 Amphiphilic drug-oligomer conjugates with hydrolyzable lipophile components and methods for making and using the same |
| 12/28/2000 | WO2000078301A1 Anesthetic composition for intravenous injection comprising propofol |
| 12/28/2000 | WO2000078297A2 Stable xylometazoline and oxymetazoline solution |
| 12/28/2000 | WO2000078295A1 Microencapsulated bovine adrenal medulla chromaffin cell-drug for alleviating pain |
| 12/28/2000 | WO2000078294A2 Oral administration form for administering a fixed tramadol and diclofenac combination |
| 12/28/2000 | WO2000078293A1 New formulation |
| 12/28/2000 | WO2000078292A1 Quickly disintegrating solid preparations |
| 12/28/2000 | WO2000078291A1 Composition of paroxetine methanesulfonate |
| 12/28/2000 | WO2000078290A2 Pharmaceutical composition comprising a salt of paroxetine |
| 12/28/2000 | WO2000078289A1 Multilayered tablet for administration of a fixed combination of tramadol and diclofenac |
| 12/28/2000 | WO2000078288A2 Novel process for paroxetine compositions |
| 12/28/2000 | WO2000078287A1 Antibiotic-natural polysaccharide polymer adducts |
| 12/28/2000 | WO2000078286A1 Steroid solution aerosol products with enhanced chemical stability |
| 12/28/2000 | WO2000078285A1 Controlled release of therapeutics by in-situ entrapment by matrix cross-linking |
| 12/28/2000 | WO2000078284A1 Stable benzimidazole formulation |
| 12/28/2000 | WO2000078272A2 Guerbet alcohols |
| 12/28/2000 | WO2000078259A1 Enhanced wound coverage to enhance wound healing |